<DOC>
	<DOC>NCT00376896</DOC>
	<brief_summary>This is a three-period crossover study to compare GW876008 and placebo to see if GW876008 will normalise blood flow responses after different emotional stimuli.</brief_summary>
	<brief_title>Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Corticotropin-Releasing Hormone</mesh_term>
	<criteria>The subject should not have been taking and medication for the treatment of IBS for 1 month prior to the study Negative serum pregnancy tests (serum aHCG negative) at Screening (Visit 1), and negative urine pregnancy tests at Visits 1, 2, 3 prior to study medication dose. Nontobacco user (abstinence from tobacco use for at least 1 month before the start of the study). Normal electrocardiogram (subjects must have no clinically significant abnormalities on a 12lead ECG at screen). Subjects who are pregnant or nursing. Current evidence, or history of (at any time in the past) of a biochemical or structural abnormality of the digestive tract. including (but not limited to): inflammatory bowel disease (Crohn's disease or ulcerative colitis); functional dyspepsia; lactose intolerance, not on a stable diet; Celiac Disease Subjects who are taking NSAIDs on a regular basis or within 48 hours of a study day. The subject has a positive prestudy urine drug/alcohol screen. A positive prestudy HIV 1 / 2, Hepatitis B surface antigen or positive Hepatitis C antibody result within 3 months of the start of the study.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>IBS fMRI</keyword>
</DOC>